Use of Serotonergic Drugs in Canada for Gastrointestinal Motility Disorders: Results of a Retrospective Cohort Study

Table 2

Baseline characteristics.

	Use of serotonergic drugs ()	No serotonergic drugs ()
Age at symptom onset	1st decade: 29 (90.6%); 2nd decade: 1 (3.1%); 3rd decade: 1 (3.1%); 4th decade: 0 (0.0%); ≥5th decade: 1 (3.1%)	1st decade: 65 (67.7%); 2nd decade: 1 (1.0%); 3rd decade: 5 (5.2%); 4th decade: 8 (8.3%); ≥5th decade: 10 (10.4%)	0.17
Female	32 (100%)	93 (96.9%)	0.57
Constipation-dominant	27 (84.4%)	71 (74.0%)	0.34
Diffuse motility disorder	9 (28.1%)	12 (12.5%)	0.05
Underwent surgery	23 (71.9%)	74 (77.1%)	0.63